#ASPChat Transcript
Healthcare social media transcript of the #ASPChat hashtag.
– ().
See #ASPChat Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | Melissa Johnson @IDPharmacist @ASP_Chat Happy Thursday Night! #ASPchat |
 | Mike Stevens @Dr_Mike_Stevens @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD .A1 = what interventions/ strategies are best linked with decreases in GN antibiotic resistance #ASPChat |
 | Brad Langford @BRxAD @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD A multi-center interventional study that would be interesting - how can we use technology to impact antibiotic decision making at the point of care/point of order entry (by better estimating benefits vs. risks of tx)? #ASPChat |
 | Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD RE: Q1. I have been thinking about this all week. No one answer. Best so far is: What one intervention is most vital to preserving antibiotics for our children and the future? #ASPchat |
| Brad Langford @BRxAD RT @ASP_Chat: Q1. If you had an 🧠🤖🌐 AI super computer that connected all EMRs and databases across the world and you could ask it to analyze one question about abx stewardship, what would it be? #ASPchat (pretend EMRs are accurate for this exercise) https://t.co/6TcvfZVvFZ |
| Brad Langford @BRxAD RT @ASP_Chat: Q1. If you had an 🧠🤖🌐 AI super computer that connected all EMRs and databases across the world and you could ask it to analyze one question about abx stewardship, what would it be? #ASPchat (pretend EMRs are accurate for this exercise) https://t.co/6TcvfZVvFZ |
 | CDC Emerging Infections @CDC_NCEZID NEW from CDC's Be Antibiotics Aware: Materials for patients and healthcare professionals now available in a variety of languages! https://t.co/4NcSBetUtv #BeAntibioticsAware #ASPChat |
 | Brandon Dionne @BWDionne @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD What is the most efficient antimicrobial stewardship strategy when resources are limited? Review all antibiotics (time intensive), targeted review (may miss opportunities), improve use of order sets/pathways (not always applicable). #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD A multi-center interventional study that would be interesting - how can we use technology to impact antibiotic decision making at the point of care/point of order entry (by better estimating benefits vs. risks of tx)? #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: NEW from CDC's Be Antibiotics Aware: NEW from CDC's Be Antibiotics Aware: Materials for patients and healthcare professionals now available in a variety of languages! https://t.co/4NcSBetUtv #BeAntibioticsAware #ASPChat |
 | Jamie Kisgen @KisgenUF @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD A1. Wow, tough questions. First thing that comes to mind is a large multicenter outcome study looking at different durations of therapy for gram-negative bacteremia. 🤔 #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @Dr_Mike_Stevens @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD So much overlap within this realm, is it a good thing or a bad thing? Probably a little of both and it all depends on the specific scenario, like everything in ID, lol! #ASPchat |
| Melissa Johnson @IDPharmacist @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD Which strategies are associated with the best real world outcomes? Ie 🔽 LOS, mortality, readmission rate, resistance, etc. #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BWDionne: @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD What is the most efficient antimicrobial stewardship strategy when resources are limited? Review all antibiotics (time intensive), targeted review (may miss opportunities), improve use of order sets/pathways (not always applicable). #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @BWDionne @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD Retrospective chart review... 🤮 #ASPchat |
 | Julie Ann Justo @julie_justo @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD A1. What risk factors best predict antimicrobial resistance such that we can avoid broad-spectrum abx with confidence? #ASPchat #clinicaldecisionsupport |
 | #ASPchat @ASP_Chat Q2. What metric would you first 👀 look to for prioritizing antimicrobial stewardship research? Why? #ASPchat Note: This does not have to be your priority metric, rather is your starting point. |
| Brad Langford @BRxAD @KisgenUF @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD The BALANCE Trial (Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness) looks at GP and GN bacteremia and may help to answer this question https://t.co/dKOCpIazRJ #ASPChat |
| Jamie Kisgen @KisgenUF @IDPharmacist @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD I would tag on to that, what are the differences in those same metrics between hospitals with and without robust stewardship programs in place. Could also stratify by hospital size, type (teaching/community), and region. #ASPchat |
 | Todd McCarty 💊🐉👨⚕️ @TMcCarty2010 @ASP_Chat Time to change from empiric to targeted therapy (or none, if no infection found). #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q2. What metric would you first 👀 look to for prioritizing antimicrobial stewardship research? Why? #ASPchat Note: This does not have to be your priority metric, rather is your starting point. |
 | Nick Bennett @nbennett04 Great point. How can we automate our EMR to help providers make informed decisions in situations that antibiotics have little utility-without alert fatigue? Has to be a home run 🚨/intervention. #ASPchat https://t.co/7yh4ERadZo |
| Mike Stevens @Dr_Mike_Stevens #ASPChat going for the gold with question #1! At this point it would be great if we could meaningfully collect real-time, (optimally) risk-adjusted, cross-compared Abx use data!! We are a long way from gold as a community |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat A2. When it comes down to it the thing that really matters is patient outcomes. I would start there. Unfortunately this is one of the harder metrics to accurately measure. #ASPchat |
| Nick Bennett @nbennett04 @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD A1: can it identify patients who can have their antibiotics stopped based on low risk profiles? #ASPChat |
| Brad Langford @BRxAD @BWDionne @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD We looked at 73 hospitals to evaluate the association with different stewardship components (both structural and strategic) and antibiotic use in hospitals... hoping to publish soon. May help to add some support for hospitals with limited resources. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @IDPharmacist: @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD Which strategies are associated with the best real world outcomes? Ie 🔽 LOS, mortality, readmission rate, resistance, etc. #ASPChat |
| CDC Emerging Infections @CDC_NCEZID CDC released data in its AR Investment Map, which shows early progress by states to combat #AntibioticResistance —when germs no longer respond to the drugs designed to kill them. https://t.co/vd6BFP3iaf #CDCfightsAR #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @julie_justo: @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD A1. What risk factors best predict antimicrobial resistance such that we can avoid broad-spectrum abx with confidence? #ASPchat #clinicaldecisionsupport |
| Jamie Kisgen @KisgenUF @BRxAD @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD That is awesome. Can’t wait to see the results! #ASPChat https://t.co/U1ix5hxItU |
| Melissa Johnson @IDPharmacist @CDC_NCEZID This can be a valuable resource for stewards! #antimicrobialstewadship #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @julie_justo @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD We need one of these things from #StarTrek to help us detect MDROs at POC! #ASPchat https://t.co/4PlQeNUv8A |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @KisgenUF @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD The BALANCE Trial (Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness) looks at GP and GN bacteremia and may help to answer this question https://t.co/dKOCpIazRJ #ASPChat |
| Brad Langford @BRxAD @Dr_Mike_Stevens Definitely a challenge that needs addressing! Often difficult to tease out the modifiable and non-modifiable factors contributing to antibiotic use in order to risk adjust #ASPChat |
| Melissa Johnson @IDPharmacist @BRxAD @BWDionne @ASP_Chat @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD Very Cool! Looking forward to seeing that. #ASPchat https://t.co/ecON1Vf8mq |
| Jamie Kisgen @KisgenUF RT @IDstewardship: @ASP_Chat A2. When it comes down to it the thing that really matters is patient outcomes. I would start there. Unfortunately this is one of the harder metrics to accurately measure. #ASPchat |
 | Dr. Chris Braden @DrBraden_NCEZID Healthcare Professionals: Register now for CDC’s free #CE course on #antibiotic stewardship: https://t.co/HQg1LiCmdr #ASPChat https://t.co/nLc1YpRzfj |
| #ASPchat @ASP_Chat Q3. Focusing on the 🏘 outpatient setting, what are your priority research areas for #antibiotic stewardship? #ASPchat https://t.co/vkeDn1jmXM |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @nbennett04 Agree. The future is clearly going to be heavily dependent upon technology. Alert fatigue is such an important issue too. Will be a major challenge to balance clinical skills of a doctor with the capacity of a system. Value of provider autonomy cannot be overshadowed. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q3. Focusing on the 🏘 outpatient setting, what are your priority research areas for #antibiotic stewardship? #ASPchat https://t.co/vkeDn1jmXM |
| Mike Stevens @Dr_Mike_Stevens @BRxAD .Definitely! We have been working on this in the hospital epidemiology community for decades and still there is room for improvement! Need to apply lessons learned on metrics from the infection prevention community to #AntimicrobialStewardship #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship An excellent resource indeed!!!! Especially for prepping future researchers 👍 #ASPchat https://t.co/ZGl06n6aJU |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @Dr_Mike_Stevens: #ASPChat going for the gold with question #1! At this point it would be great if we could meaningfully collect real-time, (optimally) risk-adjusted, cross-compared Abx use data!! We are a long way from gold as a community |
| Brandon Dionne @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Where do I even begin?...No, seriously, someone please tell me where we even begin with outpatient stewardship. #ASPChat https://t.co/BomR6lEXo5 |
| Melissa Johnson @IDPharmacist @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. How can we do a better job of optimizing durations & appropriate prescribing of outpatient #antibiotic use given the large number of providers in play? #ASPchat |
| Mike Stevens @Dr_Mike_Stevens @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Data! #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @nbennett04 @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD That sounds really cool. I would totally invest in a "d/c antibiotics identifier" machine... it would also need to serve a dual purpose of treating prescriber anxiety 😉 @BradSpellberg #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: CDC released data in its AR Investment Map, which shows early progress by states to combat #AntibioticResistance —when germs no longer respond to the drugs designed to kill them. https://t.co/vd6BFP3iaf #CDCfightsAR #ASPChat |
| Mike Stevens @Dr_Mike_Stevens @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Need to start with meaningful, normalized antibiotic data capture. Bonus points for risk adjustment and inter-facility cross comparison! If we can't measure it, we can't improve it #ASPChat |
| Jamie Kisgen @KisgenUF @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Data, Data, Data...we need a better understanding of the problem and identify real world, high impact interventions to move the needle. How do we give real time feedback to providers, peer to peer comparisons, and what are the best methods for educating the public? #ASPchat |
| Brad Langford @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Measuring (and sometimes even defining) "appropriateness" is important. This can be helpful to provide actionable information to prescribers via peer comparison #ASPchat |
 | Kevin Schwartz @DrKevinSchwartz @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD You need to think differently and on a larger scale than in hospitals. Identify a target audience, and a behaviour you wish to change. You need access to AMU data as well as partners involved in healthcare quality and delivery #ASPCHAT |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Q3. How can we change patient perceptions so that they put less pressure on prescribers and can leave satisfied without an antibiotic when it is not indicated (and can actually hurt them!). #ASPchat #LetYourDoctorDecide |
| Mike Stevens @Dr_Mike_Stevens @ASP_Chat .A2: The holy grail of #AntimicrobialStewardship is reducing the emergence of antibiotic resistance! If we focused here many other things would follow along (decreased LOS, morbidity, mortality, et cetera) #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @Dr_Mike_Stevens @BRxAD I am surprised we haven't seen more talk about "stewardship bundles", kind of taking ideas from infection control. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BWDionne: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Where do I even begin?...No, seriously, someone please tell me where we even begin with outpatient stewardship. #ASPChat https://t.co/BomR6lEXo5 |
| Mike Stevens @Dr_Mike_Stevens @IDstewardship @nbennett04 @ASP_Chat @BRxAD @accpinfdprn @khalideljaaly @SIDPharm @CRE_REDUCE @UKCPAPIN @BradSpellberg @PaulSaxMD @JGPharmD .Replace antibiotics as the anxiolytics of choice... #ASPChat |
| Kevin Schwartz @DrKevinSchwartz @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD The research should focus on what drives antibiotic prescribing variability and inappropriateness. We then need to study which type of interventions are effective and sustainable #ASPchat |
| Brad Langford @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Patient focused interventions like viral prescribing pads are really neat but research is needed to show they are effective (and how to optimally use them) https://t.co/OVaNAaJCva #ASPchat |
| #ASPchat @ASP_Chat Q4. If you had the resources to adress any one question at your practice site / institution, what would it be? 🤷♂️🤷♀️ #ASPchat https://t.co/AZmnoPBUdQ |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @IDPharmacist: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. How can we do a better job of optimizing durations & appropriate prescribing of outpatient #antibiotic use given the large number of providers in play? #ASPchat |
| Mike Stevens @Dr_Mike_Stevens @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Well stated! The holy grail of Abx consumption metrics would be normalized, risk-adjusted, and would measure appropriateness of therapy! That's a tough call in a field where 40-60% of best practice is dictated by C-III level evidence though! #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q4. If you had the resources to adress any one question at your practice site / institution, what would it be? 🤷♂️🤷♀️ #ASPchat https://t.co/AZmnoPBUdQ |
 | Kristen Cincotta @kscincotta RT @CDC_NCEZID: NEW from CDC's Be Antibiotics Aware: NEW from CDC's Be Antibiotics Aware: Materials for patients and healthcare professionals now available in a variety of languages! https://t.co/4NcSBetUtv #BeAntibioticsAware #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @Dr_Mike_Stevens: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Need to start with meaningful, normalized antibiotic data capture. Bonus points for risk adjustment and inter-facility cross comparison! If we can't measure it, we can't improve it #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Measuring (and sometimes even defining) "appropriateness" is important. This can be helpful to provide actionable information to prescribers via peer comparison #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @KisgenUF: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Data, Data, Data...we need a better understanding of the problem and identify real world, high impact interventions to move the needle. How do we give real time feedback to providers, peer to peer comparisons, and what are the best methods for educating the public? #ASPchat |
| Kevin Schwartz @DrKevinSchwartz @IDstewardship @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Interestingly this is probably less of an issue than the prescriber thinking that the patient expects an antibiotic. Aligning provider and patient education is important but improving provider communication skills can make a big difference #ASPchat |
 | Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @ASP_Chat A4. How can I get outpatient antibiotic use data at institutional urgent care centers? #ASPchat |
| Brad Langford @BRxAD The @VeteransHealth has a nice commentary in @ICHEJournal on research gaps that apply across multiple settings https://t.co/1lGFSkAIq6 #ASPchat https://t.co/r8iDW2ZQMd |
| Brandon Dionne @BWDionne @ASP_Chat What is the appropriate duration of antibiotics in neutropenic fever? There is some emerging evidence that you don't need to wait for engraftment, but some patients are still on cefepime for weeks waiting for resolution of neutropenia. #ASPChat |
| Nick Bennett @nbennett04 @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3: how can rapid diagnostics be incorporated into ambulatory practice? Are they effective here? #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @Dr_Mike_Stevens @ASP_Chat We should do an #ASPchat on lab problems. Impact on reducing resistance only as good as your data... and the data ain't so good... especially outpatient... I [regretfully] think it's a lost cause 99% of the time... |
| Mike Stevens @Dr_Mike_Stevens @IDstewardship @BRxAD .Definitely! We explored this a few years back but realized it's harder w/ #AntimicrobialStewardship (CLABSI, CAUTI, VAP are natural targets for bundles, outcome metrics like 'abx resistance' are less so...). I think there is a paper in here somewhere! #ASPChat |
| CDC Emerging Infections @CDC_NCEZID Be Antibiotics Aware print materials now available to order via CDC-INFO On Demand! Visit https://t.co/VKhs5lCqJF and select “antibiotic use” from the drop-down menu. #antibiotics #ASPChat |
 | Katie Alfond @KAlfond_PharmD What is the most (time) efficient way for pharmacists to identify individual patient misconceptions about abx when they pick up their Rx and then how can they clear the air on a case by case basis ? #ASPChat https://t.co/stbtrCffF6 |
| Nick Bennett @nbennett04 RT @BRxAD: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Measuring (and sometimes even defining) "appropriateness" is important. This can be helpful to provide actionable information to prescribers via peer comparison #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Sustainability is something many studies completely fail to address. Great point that needs to be included if we are going to identify valuable interventions worth our investments. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Patient focused interventions like viral prescribing pads are really neat but research is needed to show they are effective (and how to optimally use them) https://t.co/OVaNAaJCva #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: The @VeteransHealth has a nice commentary in @ICHEJournal on research gaps that apply across multiple settings https://t.co/1lGFSkAIq6 #ASPchat https://t.co/r8iDW2ZQMd |
| Mike Stevens @Dr_Mike_Stevens @IDstewardship @ASP_Chat This is a struggle! All #AntimicrobialStewardship work benefits from real-time, creative IT solutions/ lab integration. I definitely picked up some tricks/ tips from a prior #ASPChat on integrating with the lab so think this is a great forum for it! |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @TheFebrileMuse @KisgenUF @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @Commpharmacy @cvspharmacy @Walgreens @mmPharmD What do you think of posters? How is the feedback from providers and nurses? Do they seem to work? Any notes on what seems to help make them more effective? #ASPchat |
| Brad Langford @BRxAD Would be neat to build in a system in CPOE to randomize interventions (structure of order sets, microbiology selective reporting/comments, etc.) to try to optimize different "nudging" interventions #ASPChat https://t.co/AVb9nzBT4f |
| Mike Stevens @Dr_Mike_Stevens @IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Good point! 'Taking the foot of the gas' leads to 'regression to the mean' for most #AntimicrobialStewardship interventions; I think sustainability takes resources and longitudinal commitment #ASPChat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Getting the data and measuring the impact of patient interventions would be my priority. But also would like to explore how to create patient interventions that result in doctors NOT getting bad patient reviews for avoiding antibiotics. #ASPchat |
| #ASPchat @ASP_Chat Q5. What do you perceive as priority research areas for helping 🕵️♂️🕵️♀️ regulatory bodies fairly asses institutional antimicrobial stewardship efforts? #ASPchat https://t.co/WVfpf6eJAr |
 | David Ha @DHpharmd @ASP_Chat A4. Does #AntimicrobialStewardship reduce #AntibioticResistance? #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @IDstewardship: @ASP_Chat A2. When it comes down to it the thing that really matters is patient outcomes. I would start there. Unfortunately this is one of the harder metrics to accurately measure. #ASPchat |
| Brandon Dionne @BWDionne @SoonToBePharmD Great point! How do we get community pharmacists (the biggest group of pharmacists) more involved in outpatient antimicrobial stewardship? Perhaps one of the biggest untapped resources? #ASPChat |
| Kevin Schwartz @DrKevinSchwartz @SoonToBePharmD The problem is the pharmacist contact the patient after the Rx has been written. We need novel models of outpatient care that incorporates pharmacists into the clinical decision making BEFORE the Rx is written to influence and improve care #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @Dr_Mike_Stevens: @IDstewardship @ASP_Chat This is a struggle! All #AntimicrobialStewardship work benefits from real-time, creative IT solutions/ lab integration. I definitely picked up some tricks/ tips from a prior #ASPChat on integrating with the lab so think this is a great forum for it! |
| Brandon Dionne @BWDionne RT @Dr_Mike_Stevens: @IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Good point! 'Taking the foot of the gas' leads to 'regression to the mean' for most #AntimicrobialStewardship interventions; I think sustainability takes resources and longitudinal commitment #ASPChat |
| Mike Stevens @Dr_Mike_Stevens @IDstewardship @TheFebrileMuse @KisgenUF @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Providing meaningful education to patients on the dangers of antibiotics (resistance, et cetera) probably more useful than general education (bacterial vs viral infxns, et cetera). TVs in waiting areas, posters, whatever format probably less important than the message #ASPChat |
| Brandon Dionne @BWDionne RT @kevin_kls: @SoonToBePharmD The problem is the pharmacist contact the patient after the Rx has been written. We need novel models of outpatient care that incorporates pharmacists into the clinical decision making BEFORE the Rx is written to influence and improve care #ASPchat |
| Mike Stevens @Dr_Mike_Stevens @kevin_kls @SoonToBePharmD .True; to help facilitate optimal initial prescribing though need better deployment (as well as novel) rapid diagnostic testing! Hard to ask a patient who has one day of antibiotics left to change to a narrower antibiotic when a cx returns, practically #ASPChat |
| David Ha @DHpharmd @BWDionne @SoonToBePharmD Yes! First things first, get community pharmacists real time access to patient information: diagnoses, labs, medication history, etc. Difficult to intervene on something when you know nothing about it #ASPchat #KnowledgeIsPower |
| Todd McCarty 💊🐉👨⚕️ @TMcCarty2010 @ASP_Chat Hopefully the recently developed SAR measurement from the @CDCgov proves helpful to fulfill this role and become widespread. #ASPchat |
| CDC Emerging Infections @CDC_NCEZID Healthcare Professionals: Register now for CDC’s free #CE course on #antibiotic stewardship: https://t.co/77W7PV9tHl #ASPChat https://t.co/bLf8uom5uF |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @nbennett04 @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD How to incorporate rapid diagnostics into operations so they can be optimally employed is a topic of interest. Turn around time is a big deal. #ASPchat |
| Jamie Kisgen @KisgenUF A5. We need more outcome data and benchmarks for setting goals. SAAR may be a start but we need more transparency on what best practice looks like. Its one thing to say a policy or protocol is in place, it’s another to say they are making a difference. #ASPChat https://t.co/4u6E3CNPvC |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: Be Antibiotics Aware print materials now available to order via CDC-INFO On Demand! Visit https://t.co/VKhs5lCqJF and select “antibiotic use” from the drop-down menu. #antibiotics #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @SoonToBePharmD: What is the most (time) efficient way for pharmacists to identify individual patient misconceptions about abx when they pick up their Rx and then how can they clear the air on a case by case basis ? #ASPChat https://t.co/stbtrCffF6 |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @ASP_Chat Also would invest in ideas to make rapid diagnosis of syndromes where antibiotics are most misused. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q5. What do you perceive as priority research areas for helping 🕵️♂️🕵️♀️ regulatory bodies fairly asses institutional antimicrobial stewardship efforts? #ASPchat https://t.co/WVfpf6eJAr |
| Brad Langford @BRxAD @DHpharmd @BWDionne @SoonToBePharmD Agree... an indication on all antibiotic prescriptions would be a good first start #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @Dr_Mike_Stevens: @IDstewardship @ASP_Chat This is a struggle! All #AntimicrobialStewardship work benefits from real-time, creative IT solutions/ lab integration. I definitely picked up some tricks/ tips from a prior #ASPChat on integrating with the lab so think this is a great forum for it! |
| Jamie Kisgen @KisgenUF RT @kevin_kls: @SoonToBePharmD The problem is the pharmacist contact the patient after the Rx has been written. We need novel models of outpatient care that incorporates pharmacists into the clinical decision making BEFORE the Rx is written to influence and improve care #ASPchat |
| Mike Stevens @Dr_Mike_Stevens @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): Govt should put big $$$ into best possible multicenter trials focused on the big question in stewardship (what strategies lead to decreased antibiotic resistance? What resources are needed to optimize these?) |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: Would be neat to build in a system in CPOE to randomize interventions (structure of order sets, microbiology selective reporting/comments, etc.) to try to optimize different "nudging" interventions #ASPChat https://t.co/AVb9nzBT4f |
| Brandon Dionne @BWDionne @DHpharmd @SoonToBePharmD I'm still not sure why at the very least the diagnosis/indication isn't a standard part of the prescription. #ASPChat |
| David Ha @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Same old song but our PCPs need more TIME with patients to manage expectations and explain rationale. More time to be doctors not box checkers. This is the #1 through #100 root cause of #AntimicrobialStewardship issues in our experience #ASPchat |
| Mike Stevens @Dr_Mike_Stevens @IDstewardship @nbennett04 @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Yes! Cost to the patient also an important consideration #ASPChat |
| Katie Alfond @KAlfond_PharmD RT @BRxAD: @DHpharmd @BWDionne @SoonToBePharmD Agree... an indication on all antibiotic prescriptions would be a good first start #ASPchat |
| Kevin Schwartz @DrKevinSchwartz @IDstewardship @nbennett04 @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD RDTs will not be the saviour of community ASP. They will be expensive with false +/- Conditions like sinusitis have clinic criteria and those where RDTs are useful like pharyngitis are infrequently used. Behaviour and culture changes are needed #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat Where I trained the #1 question would be: How the heck are we supposed to dose this #colistin???? #ASPchat ...not sure if we will ever really know. Even describing a dose is a challenge!!! (IU, MG, CMS, CBA, 🤢) |
| #ASPchat @ASP_Chat Q6. When you need to pick a new #antibioticstewardship research or MUE question locally, where/who do you look to for guidance? #ASPchat https://t.co/2yPznK08Ot |
| Kevin Schwartz @DrKevinSchwartz @IDstewardship @nbennett04 @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD RDTs are coming regardless so we should make sure they are well studied and used appropriately #ASPchat |
| Brad Langford @BRxAD @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Recent study shows this is the case in primary care too...doctors seeing more patients per day were more likely to prescribe unnecessary Rx https://t.co/hHuZw45tYP #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @Dr_Mike_Stevens: @IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Good point! 'Taking the foot of the gas' leads to 'regression to the mean' for most #AntimicrobialStewardship interventions; I think sustainability takes resources and longitudinal commitment #ASPChat |
| David Ha @DHpharmd @ASP_Chat A6. Twitter #ASPchat |
| Cody L @CodyL44740165 @ASP_Chat A4. How much extra time are patients on sub/supratherapeutic doses of vancomycin due to improperly drawn trough levels? #ASPchat | |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: @ASP_Chat A4. Does #AntimicrobialStewardship reduce #AntibioticResistance? #ASPchat |
| Brandon Dionne @BWDionne @DrJRMarcelin @ASP_Chat Also important that these tests are not cost-prohibitive. The one we have is restricted; by the time they get approval, they have often already ordered individual tests for half of the pathogens, so it is not cost-effective. #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @BWDionne @SoonToBePharmD Ditto. Community pharmacists really care about safe antibiotic use. When I talk to them they want to be involved and help, but they aren't being empowered like they could be and need support/direction. #ASPchat cc: @Commpharmacy |
| Mike Stevens @Dr_Mike_Stevens @ASP_Chat .It seems like great questions come up daily on the 'front lines' of #AntimicrobialStewardship! We keep a running list of possible projects and discuss monthly. Could also mine these #ASPChat sessions for great ideas, too!! |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @BWDionne @ASP_Chat And also easy to use and interpret! Essential for application in urgent care settings #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @BRxAD: @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Recent study shows this is the case in primary care too...doctors seeing more patients per day were more likely to prescribe unnecessary Rx https://t.co/hHuZw45tYP #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @DHpharmd: @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Same old song but our PCPs need more TIME with patients to manage expectations and explain rationale. More time to be doctors not box checkers. This is the #1 through #100 root cause of #AntimicrobialStewardship issues in our experience #ASPchat |
| Brad Langford @BRxAD @ASP_Chat Examining local practice concerns, bouncing ideas off mentors and peers, considering feasibility based on available data #ASPChat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @TMcCarty2010: @ASP_Chat Hopefully the recently developed SAR measurement from the @CDCgov proves helpful to fulfill this role and become widespread. #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @Dr_Mike_Stevens: @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): Govt should put big $$$ into best possible multicenter trials focused on the big question in stewardship (what strategies lead to decreased antibiotic resistance? What resources are needed to optimize these?) |
| Kevin Schwartz @DrKevinSchwartz @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Better communication skills shortens visit time, improves satisfaction, and reduces inappropriate antibiotic use #ASPchat https://t.co/X4FUxbmdPI |
 | Elena Candia F. @ElenaCandiaF RT @DrKhabbazCDC: Healthcare Professionals: Register now for CDC’s free #CE course on #antibiotic stewardship: Healthcare Professionals: Register now for CDC’s free #CE course on #antibiotic stewardship: https://t.co/HQg1LiCmdr #ASPChat https://t.co/nLc1YpRzfj |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @kevin_kls: @SoonToBePharmD The problem is the pharmacist contact the patient after the Rx has been written. We need novel models of outpatient care that incorporates pharmacists into the clinical decision making BEFORE the Rx is written to influence and improve care #ASPchat |
| Brad Langford @BRxAD RT @kevin_kls: @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Better communication skills shortens visit time, improves satisfaction, and reduces inappropriate antibiotic use #ASPchat https://t.co/X4FUxbmdPI |
| David Ha @DHpharmd @Dr_Mike_Stevens @ASP_Chat Agreed, honestly just asking "why is this happening", "how can we be better" in day to day practice reveal some of the most impactful research questions #ASPchat |
| Brandon Dionne @BWDionne RT @kevin_kls: @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Better communication skills shortens visit time, improves satisfaction, and reduces inappropriate antibiotic use #ASPchat https://t.co/X4FUxbmdPI |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: @BWDionne @SoonToBePharmD Yes! First things first, get community pharmacists real time access to patient information: @BWDionne @SoonToBePharmD Yes! First things first, get community pharmacists real time access to patient information: diagnoses, labs, medication history, etc. Difficult to intervene on something when you know nothing about it #ASPchat #KnowledgeIsPower |
| David Ha @DHpharmd RT @kevin_kls: @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Better communication skills shortens visit time, improves satisfaction, and reduces inappropriate antibiotic use #ASPchat https://t.co/X4FUxbmdPI |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: Healthcare Professionals: Register now for CDC’s free #CE course on #antibiotic stewardship: Healthcare Professionals: Register now for CDC’s free #CE course on #antibiotic stewardship: https://t.co/77W7PV9tHl #ASPChat https://t.co/bLf8uom5uF |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @KisgenUF: A5. We need more outcome data and benchmarks for setting goals. SAAR may be a start but we need more transparency on what best practice looks like. Its one thing to say a policy or protocol is in place, it’s another to say they are making a difference. #ASPChat https://t.co/4u6E3CNPvC |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @Dr_Mike_Stevens: @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): Govt should put big $$$ into best possible multicenter trials focused on the big question in stewardship (what strategies lead to decreased antibiotic resistance? What resources are needed to optimize these?) |
| #ASPchat @ASP_Chat 🙌🏼 Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. 🗣 Heads up! Mark down June 13th for a chat on #IDintheED via a 💪🏽 mega-collaboration between @accpinfdprn @SIDPharm @ASHP_EMPharm @accpemedprn @aaeminfo. More to come on that! |
| #ASPchat @ASP_Chat Final tweet 👉🏼 here is some data and discussion from @IDstewardship and @BRxAD about the #ASPchat activities 📲 https://t.co/grQioYdn6x Hope you find it interesting!!! https://t.co/qDfNPqp6JB |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @Dr_Mike_Stevens: @IDstewardship @nbennett04 @BRxAD @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Yes! Cost to the patient also an important consideration #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Final tweet 👉🏼 here is some data and discussion from @IDstewardship and @BRxAD about the #ASPchat activities 📲 https://t.co/grQioYdn6x Hope you find it interesting!!! https://t.co/qDfNPqp6JB |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: 🙌🏼 Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. 🗣 Heads up! Mark down June 13th for a chat on #IDintheED via a 💪🏽 mega-collaboration between @accpinfdprn @SIDPharm @ASHP_EMPharm @accpemedprn @aaeminfo. More to come on that! |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @ASP_Chat A5. Agreed with both. SAAR is promising. Need funding commitment from govt to assist institutions in achieving regulatory requirements. Especially critical access hospitals and outpatient clinics. How else are we expected to reduce inappropriate use by 50% by 2020? #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q6. When you need to pick a new #antibioticstewardship research or MUE question locally, where/who do you look to for guidance? #ASPchat https://t.co/2yPznK08Ot |
| Brandon Dionne @BWDionne RT @ASP_Chat: 🙌🏼 Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. 🗣 Heads up! Mark down June 13th for a chat on #IDintheED via a 💪🏽 mega-collaboration between @accpinfdprn @SIDPharm @ASHP_EMPharm @accpemedprn @aaeminfo. More to come on that! |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: @ASP_Chat A6. Twitter #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Recent study shows this is the case in primary care too...doctors seeing more patients per day were more likely to prescribe unnecessary Rx https://t.co/hHuZw45tYP #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @ASP_Chat A6. Lots of great questions come up on rounds when I am the ID attending on hospital service #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @DHpharmd: @Dr_Mike_Stevens @ASP_Chat Agreed, honestly just asking "why is this happening", "how can we be better" in day to day practice reveal some of the most impactful research questions #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BWDionne: @DrJRMarcelin @ASP_Chat Also important that these tests are not cost-prohibitive. The one we have is restricted; by the time they get approval, they have often already ordered individual tests for half of the pathogens, so it is not cost-effective. #ASPChat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @kevin_kls: @DHpharmd @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt @real_idpharmd @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Better communication skills shortens visit time, improves satisfaction, and reduces inappropriate antibiotic use #ASPchat https://t.co/X4FUxbmdPI |
| David Ha @DHpharmd @KisgenUF Agree 💯% here. Simply having passive protocols and policies without any real outcomes to show for it just furthers the "checking the box" approach, which can add time and cost, achieves no outcome and increases doubt in the system #ASPchat |
| David Ha @DHpharmd RT @ASP_Chat: 🙌🏼 Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. 🗣 Heads up! Mark down June 13th for a chat on #IDintheED via a 💪🏽 mega-collaboration between @accpinfdprn @SIDPharm @ASHP_EMPharm @accpemedprn @aaeminfo. More to come on that! |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin Agree 💯. We have to somehow convince patients that we are on the same team when it comes to appropriate antibiotic use #ASPchat https://t.co/xrsbbmz5Wj |
| David Ha @DHpharmd RT @ASP_Chat: Final tweet 👉🏼 here is some data and discussion from @IDstewardship and @BRxAD about the #ASPchat activities 📲 https://t.co/grQioYdn6x Hope you find it interesting!!! https://t.co/qDfNPqp6JB |
| Brad Langford @BRxAD RT @ASP_Chat: Final tweet 👉🏼 here is some data and discussion from @IDstewardship and @BRxAD about the #ASPchat activities 📲 https://t.co/grQioYdn6x Hope you find it interesting!!! https://t.co/qDfNPqp6JB |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin RT @ASP_Chat: Final tweet 👉🏼 here is some data and discussion from @IDstewardship and @BRxAD about the #ASPchat activities 📲 https://t.co/grQioYdn6x Hope you find it interesting!!! https://t.co/qDfNPqp6JB |
| David Ha @DHpharmd Yes, find that students' fresh, unadulterated, sometimes idealistic views of things can give them profound insights 👍 #ASPchat https://t.co/h9ziw4QsZd |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DrJRMarcelin: @ASP_Chat A6. Lots of great questions come up on rounds when I am the ID attending on hospital service #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: Yes, find that students' fresh, unadulterated, sometimes idealistic views of things can give them profound insights 👍 #ASPchat https://t.co/h9ziw4QsZd |
| David Ha @DHpharmd @DrJRMarcelin Public health and professional organizations can play a big role here changing public opinion around expectation of antibiotics. Our pharmacy students do this constantly through community outreach 👍 #ASPchat |
| Jasmine R Marcelin, MD, FACP, FIDSA 🦠 @DrJRMarcelin @DHpharmd #AntimicrobialStewardship town halls? #ASPchat |
#ASPChat content from Twitter.